Rheumatology Advance Access published online on September 13, 2005
Rheumatology, doi:10.1093/rheumatology/kei041
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Arthritis Research Campaign Epidemiology Unit, University of Manchester, Manchester
* To whom correspondence should be addressed. Objectives. Linkage and association of rheumatoid arthritis (RA) and rheumatoid factor (RF)-negative juvenile idiopathic arthritis (JIA) has previously been demonstrated to the type 1 diabetes (T1D) locus, IDDM5, on chromosome 6q25. An association of a methionine-to-valine polymorphism (rs237025, 163A Methods. The SUMO4 SNP was genotyped in 875 RA patients, 668 JIA patients and 484 healthy controls using a TaqMan® allelic discrimination assay. Allele and genotype frequencies were compared between cases and controls using the Results. No deviation from Hardy-Weinberg equilibrium was detected in either set of cases or controls. No association was observed between rs237025 and RA ( Conclusions. The M55V substitution in the SUMO4 gene is not associated with susceptibility to RA or JIA in the UK population studied. However, other candidate genes mapping within IDDM5 remain to be investigated.
Received April 25, 2005
Accepted June 30, 2005
Concise Report
The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis
2 Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
3 Arthritis Research Campaign Epidemiology Unit, University of Manchester, Manchester; Centre for Molecular Medicine, University of Manchester, Manchester
L. J. Gibbons, E-mail: lgibbons{at}fs1.ser.man.ac.uk
![]()
Abstract
G, M55V) in the SUMO4 gene within IDDM5 has recently been described in T1D. The objective of this study was to test the hypothesis that SUMO4 is a general autoimmune susceptibility gene by investigating whether the SUMO4 polymorphism is associated with RA and/or JIA.
2 test. Analyses were also carried out with RA patients stratified by gender, age at onset, RF status, the presence of erosive disease and shared epitope status, while JIA patients were stratified by their International League of Associations for Rheumatology (ILAR) subgroup.
2=0.17, P=0.93), or with any RA subset. Similarly, there was no association between this SNP and JIA (
2=0.21, P=0.90), or with any ILAR subgroup.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Tsurumaru, E. Kawasaki, H. Ida, K. Migita, A. Moriuchi, K. Fukushima, T. Fukushima, N. Abiru, H. Yamasaki, S. Noso, et al. Evidence for the Role of Small Ubiquitin-Like Modifier 4 as a General Autoimmunity Locus in the Japanese Population J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3138 - 3143. [Abstract] [Full Text] [PDF] |
||||
